Citigroup Initiates Coverage On Syneos Health with Buy Rating, Announces $75 Price Target

Citigroup analyst Patrick Donnelly initiates coverage on Syneos Health (NASDAQ:SYNH) with a Buy rating and a $75 price target.

Benzinga · 01/07/2020 12:14

Citigroup analyst Patrick Donnelly initiates coverage on Syneos Health (NASDAQ:SYNH) with a Buy rating and a $75 price target.